Clinical Trial Update: An Open-label, 8-week Safety, Efficacy, and Assessment of Cooling Methods for Administration of CNTX-4975-05 for Knee OA [Phase 3]

View source ↗

Summary

Open-label Phase 3 trial update evaluating CNTX-4975-05 with cooling methods for knee osteoarthritis assessing safety and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Osteoarthritis

Drugs mentioned

• CNTX-4975-05

Snippet

Sponsor: Centrexion Therapeutics | Conditions: Knee Osteoarthritis | Phase 3 | Status: COMPLETED | Results posted: 2022-03-09